Cost of illness in inclusion body myositis: results from a cross-sectional study in Germany

BACKGROUND: Inclusion body myositis (IBM) is the most frequent type of myositis in elder patients with a slow chronic progression and refractory to treatment. Previous cost of illness (COI) studies in IBM used claims data to estimate direct costs in the US. No evidence exists globally on both direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Senn, Katja C., Thiele, Simone, Kummer, Karsten, Walter, Maggie C., Nagels, Klaus H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601274/
https://www.ncbi.nlm.nih.gov/pubmed/37880781
http://dx.doi.org/10.1186/s13023-023-02902-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601274/
https://www.ncbi.nlm.nih.gov/pubmed/37880781
http://dx.doi.org/10.1186/s13023-023-02902-3

Ejemplares similares